 SAN DIEGO, June 24, 2021 GLOBE NEWSWIRE -- Sorrento Therapeutics, Inc. Nasdaq: SRNE, Sorrento today announced that following its receipt of EUA approval from COFEPRIS Comisión Federal para la Protección contra Riesgos Sanitarios under registration number OFICIO: CAS107202021, it is establishing a local Sorrento Mexico Ltd subsidiary to manage commercial operations in Mexico. 